Gene: MFSD9
Official Full Name: major facilitator superfamily domain containing 9provided by HGNC
Gene Summary: Predicted to enable transmembrane transporter activity. Predicted to be involved in transmembrane transport. Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO24604 | MFSD9 Knockout cell line (HeLa) | Human | MFSD9 | 1:3~1:6 | Negative | Online Inquiry |
KO24605 | MFSD9 Knockout cell line (HCT 116) | Human | MFSD9 | 1:2~1:4 | Negative | Online Inquiry |
KO24606 | MFSD9 Knockout cell line (HEK293) | Human | MFSD9 | 1:3~1:6 | Negative | Online Inquiry |
KO24607 | MFSD9 Knockout cell line (A549) | Human | MFSD9 | 1:3~1:4 | Negative | Online Inquiry |
MFSD9 Gene Knockout Cell Lines are engineered cellular models that have undergone specific gene knockout techniques to disable the expression of the MFSD9 gene, a key player in the transport mechanisms across cellular membranes. These cell lines serve as critical tools for researchers looking to investigate the physiological roles of MFSD9, its involvement in biological pathways, and its potential implications in disease states.
The primary function of the MFSD9 Gene Knockout Cell Lines is to provide an experimental framework for examining the biological consequences of MFSD9 loss-of-function. This is achieved through the use of CRISPR/Cas9 technology, which precisely edits the genome to ensure the absence of the MFSD9 protein. By leveraging these knockout lines, scientists can assess changes in cellular metabolism, signaling pathways, and overall phenotype, shedding light on the gene's contributions to cellular function and health.
In scientific research and clinical applications, these cell lines hold significant value, particularly in studies related to cancer biology, neurodevelopment, and metabolic disorders, where MFSD9 has been implicated. The knockout models facilitate the exploration of therapeutic targets and the investigation of gene-environment interactions, enabling a deeper understanding of disease mechanisms and guiding drug development processes.
What sets our MFSD9 Gene Knockout Cell Lines apart from other gene-editing products is their rigorous quality assurance and validation process, ensuring high specificity and reproducibility in experimental outcomes. Additionally, our cell lines are extensively characterized and readily available for a wide range of applications, providing ease of use for researchers.
For researchers, clinicians, and biotechnology professionals seeking advanced models for gene function studies, our MFSD9 Gene Knockout Cell Lines represent a pivotal resource. Empowered by our dedication to excellence in biological product development, our offerings are designed to accelerate research and innovative therapies, contributing to the advancement of health sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.